Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 3774 entries
Sorted by: Best Match Show Resources per page
Erratum for the Research Article: "CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo" by P. J. Hanley, J. J. Melenhorst, S. Nikiforow, P. Scheinberg, J. W. Blaney, G. Demmler-Harrison, C. R. Cruz, S. Lam, R. A. Krance, K. S. Leung, C. A. Martinez, H. Liu, D. C. Douek, H. E. Heslop, C. M. Rooney, E. J. Shpall, A. J. Barrett, J. R. Rodgers, C. M. Bollard.

Science translational medicine

[No authors listed]
PMID: 26764153
Sci Transl Med. 2016 Jan 13;8(321):321er1. doi: 10.1126/scitranslmed.aaf1718.

No abstract available.

Cite
Erratum for the Research Article: "CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo" by P. J. Hanley, J. J. Melenhorst, S. Nikiforow, P. Scheinberg, J. W. Blaney, G. Demmler-Harrison, C. R. Cruz, S. Lam, R. A. Krance, K. S. Leung, C. A. Martinez, H. Liu, D. C. Douek, H. E. Heslop, C. M. Rooney, E. J. Shpall, A. J. Barrett, J. R. Rodgers, C. M. Bollard. Sci Transl Med. 2016;8(321):321er1doi: 10.1126/scitranslmed.aaf1718.
(2016). Erratum for the Research Article: "CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo" by P. J. Hanley, J. J. Melenhorst, S. Nikiforow, P. Scheinberg, J. W. Blaney, G. Demmler-Harrison, C. R. Cruz, S. Lam, R. A. Krance, K. S. Leung, C. A. Martinez, H. Liu, D. C. Douek, H. E. Heslop, C. M. Rooney, E. J. Shpall, A. J. Barrett, J. R. Rodgers, C. M. Bollard. Science translational medicine, 8(321), 321er1. https://doi.org/10.1126/scitranslmed.aaf1718
"Erratum for the Research Article: "CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo" by P. J. Hanley, J. J. Melenhorst, S. Nikiforow, P. Scheinberg, J. W. Blaney, G. Demmler-Harrison, C. R. Cruz, S. Lam, R. A. Krance, K. S. Leung, C. A. Martinez, H. Liu, D. C. Douek, H. E. Heslop, C. M. Rooney, E. J. Shpall, A. J. Barrett, J. R. Rodgers, C. M. Bollard." Science translational medicine vol. 8,321 (2016): 321er1. doi: https://doi.org/10.1126/scitranslmed.aaf1718
Erratum for the Research Article: "CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo" by P. J. Hanley, J. J. Melenhorst, S. Nikiforow, P. Scheinberg, J. W. Blaney, G. Demmler-Harrison, C. R. Cruz, S. Lam, R. A. Krance, K. S. Leung, C. A. Martinez, H. Liu, D. C. Douek, H. E. Heslop, C. M. Rooney, E. J. Shpall, A. J. Barrett, J. R. Rodgers, C. M. Bollard. Sci Transl Med. 2016 Jan 13;8(321):321er1. doi: 10.1126/scitranslmed.aaf1718. PMID: 26764153.
Copy Download .nbib Format: NLM
Retraction Statement: CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats.

Journal of neurochemistry

[No authors listed]
PMID: 28417467
J Neurochem. 2017 May;141(3):473-474. doi: 10.1111/jnc.13949. Epub 2017 Mar 06.

'CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats' by Hu X.-M., Liu Y.-N., Zhang H.-L., Cao S.-B., Zhang T., Chen L.-P. and Shen W. The above article from Journal of Neurochemistry,...

Cite
Retraction Statement: CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats. J Neurochem. 2017;141(3):473-474doi: 10.1111/jnc.13949.
(2017). Retraction Statement: CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats. Journal of neurochemistry, 141(3), 473-474. https://doi.org/10.1111/jnc.13949
"Retraction Statement: CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats." Journal of neurochemistry vol. 141,3 (2017): 473-474. doi: https://doi.org/10.1111/jnc.13949
Retraction Statement: CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats. J Neurochem. 2017 May;141(3):473-474. doi: 10.1111/jnc.13949. Epub 2017 Mar 06. PMID: 28417467.
Copy Download .nbib Format: NLM
Visual Genomics Analysis Studio as a Tool to Analyze Multiomic Data.

Frontiers in genetics

Hertzman RJ, Deshpande P, Leary S, Li Y, Ram R, Chopra A, Cooper D, Watson M, Palubinsky AM, Mallal S, Gibson A, Phillips EJ.
PMID: 34220932
Front Genet. 2021 Jun 17;12:642012. doi: 10.3389/fgene.2021.642012. eCollection 2021.

Type B adverse drug reactions (ADRs) are iatrogenic immune-mediated syndromes with mechanistic etiologies that remain incompletely understood. Some of the most severe ADRs, including delayed drug hypersensitivity reactions, are T-cell mediated, restricted by specific human leukocyte antigen risk alleles...

Cite
Hertzman RJ, Deshpande P, Leary S, et al. Visual Genomics Analysis Studio as a Tool to Analyze Multiomic Data. Front Genet. 2021;12:642012doi: 10.3389/fgene.2021.642012.
Hertzman, R. J., Deshpande, P., Leary, S., Li, Y., Ram, R., Chopra, A., Cooper, D., Watson, M., Palubinsky, A. M., Mallal, S., Gibson, A., & Phillips, E. J. (2021). Visual Genomics Analysis Studio as a Tool to Analyze Multiomic Data. Frontiers in genetics, 12642012. https://doi.org/10.3389/fgene.2021.642012
Hertzman, Rebecca J, et al. "Visual Genomics Analysis Studio as a Tool to Analyze Multiomic Data." Frontiers in genetics vol. 12 (2021): 642012. doi: https://doi.org/10.3389/fgene.2021.642012
Hertzman RJ, Deshpande P, Leary S, Li Y, Ram R, Chopra A, Cooper D, Watson M, Palubinsky AM, Mallal S, Gibson A, Phillips EJ. Visual Genomics Analysis Studio as a Tool to Analyze Multiomic Data. Front Genet. 2021 Jun 17;12:642012. doi: 10.3389/fgene.2021.642012. eCollection 2021. PMID: 34220932; PMCID: PMC8247644.
Copy Download .nbib Format: NLM
Establishment of the upper reference limit for thyroid peroxidase autoantibodies according to the guidelines proposed by the National Academy of Clinical Biochemistry: comparison of five different automated methods.

Auto- immunity highlights

D'Aurizio F, Metus P, Polizzi Anselmo A, Villalta D, Ferrari A, Castello R, Giani G, Tonutti E, Bizzaro N, Tozzoli R.
PMID: 26275915
Auto Immun Highlights. 2015 Dec;6(3):31-7. doi: 10.1007/s13317-015-0070-x. Epub 2015 Aug 15.

AIM OF THE STUDY: The estimation of the upper reference limit (URL) for autoantibodies against thyroid peroxidase (TPOAbs) is a controversial issue, because of an uncertainty associated with the criteria used to correctly define the reference population. In addition,...

Cite
D'Aurizio F, Metus P, Polizzi Anselmo A, et al. Establishment of the upper reference limit for thyroid peroxidase autoantibodies according to the guidelines proposed by the National Academy of Clinical Biochemistry: comparison of five different automated methods. Auto Immun Highlights. 2015;6(3):31-7doi: 10.1007/s13317-015-0070-x.
D'Aurizio, F., Metus, P., Polizzi Anselmo, A., Villalta, D., Ferrari, A., Castello, R., Giani, G., Tonutti, E., Bizzaro, N., & Tozzoli, R. (2015). Establishment of the upper reference limit for thyroid peroxidase autoantibodies according to the guidelines proposed by the National Academy of Clinical Biochemistry: comparison of five different automated methods. Auto- immunity highlights, 6(3), 31-7. https://doi.org/10.1007/s13317-015-0070-x
D'Aurizio, Federica, et al. "Establishment of the upper reference limit for thyroid peroxidase autoantibodies according to the guidelines proposed by the National Academy of Clinical Biochemistry: comparison of five different automated methods." Auto- immunity highlights vol. 6,3 (2015): 31-7. doi: https://doi.org/10.1007/s13317-015-0070-x
D'Aurizio F, Metus P, Polizzi Anselmo A, Villalta D, Ferrari A, Castello R, Giani G, Tonutti E, Bizzaro N, Tozzoli R. Establishment of the upper reference limit for thyroid peroxidase autoantibodies according to the guidelines proposed by the National Academy of Clinical Biochemistry: comparison of five different automated methods. Auto Immun Highlights. 2015 Dec;6(3):31-7. doi: 10.1007/s13317-015-0070-x. Epub 2015 Aug 15. PMID: 26275915; PMCID: PMC4633414.
Copy Download .nbib Format: NLM
Cytokine-Stimulated Phosphoflow of Whole Blood Using CyTOF Mass Cytometry.

Bio-protocol

Fernandez R, Maecker H.
PMID: 27135045
Bio Protoc. 2015 Jun 05;5(11).

The ability to assess the function of a range of cytokine, antigen receptor, and Toll-like receptor (TLR) signaling pathways in a range of immune cells could provide a kind of fingerprint of the state of the human immune system....

Cite
Fernandez R, Maecker H. Cytokine-Stimulated Phosphoflow of Whole Blood Using CyTOF Mass Cytometry. Bio Protoc. 2015;5(11)
Fernandez, R., & Maecker, H. (2015). Cytokine-Stimulated Phosphoflow of Whole Blood Using CyTOF Mass Cytometry. Bio-protocol, 5(11), .
Fernandez, Rosemary, and Maecker, Holden. "Cytokine-Stimulated Phosphoflow of Whole Blood Using CyTOF Mass Cytometry." Bio-protocol vol. 5,11 (2015).
Fernandez R, Maecker H. Cytokine-Stimulated Phosphoflow of Whole Blood Using CyTOF Mass Cytometry. Bio Protoc. 2015 Jun 05;5(11). PMID: 27135045; PMCID: PMC4847742.
Copy Download .nbib Format: NLM
Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection.

Vaccines

Swadling L, Halliday J, Kelly C, Brown A, Capone S, Ansari MA, Bonsall D, Richardson R, Hartnell F, Collier J, Ammendola V, Del Sorbo M, Von Delft A, Traboni C, Hill AV, Colloca S, Nicosia A, Cortese R, Klenerman P, Folgori A, Barnes E.
PMID: 27490575
Vaccines (Basel). 2016 Aug 02;4(3). doi: 10.3390/vaccines4030027.

An effective therapeutic vaccine for the treatment of chronic hepatitis C virus (HCV) infection, as an adjunct to newly developed directly-acting antivirals (DAA), or for the prevention of reinfection, would significantly reduce the global burden of disease associated with...

Cite
Swadling L, Halliday J, Kelly C, et al. Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection. Vaccines (Basel). 2016;4(3)doi: 10.3390/vaccines4030027.
Swadling, L., Halliday, J., Kelly, C., Brown, A., Capone, S., Ansari, M. A., Bonsall, D., Richardson, R., Hartnell, F., Collier, J., Ammendola, V., Del Sorbo, M., Von Delft, A., Traboni, C., Hill, A. V., Colloca, S., Nicosia, A., Cortese, R., Klenerman, P., Folgori, A., & Barnes, E. (2016). Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection. Vaccines, 4(3), . https://doi.org/10.3390/vaccines4030027
Swadling, Leo, et al. "Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection." Vaccines vol. 4,3 (2016). doi: https://doi.org/10.3390/vaccines4030027
Swadling L, Halliday J, Kelly C, Brown A, Capone S, Ansari MA, Bonsall D, Richardson R, Hartnell F, Collier J, Ammendola V, Del Sorbo M, Von Delft A, Traboni C, Hill AV, Colloca S, Nicosia A, Cortese R, Klenerman P, Folgori A, Barnes E. Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection. Vaccines (Basel). 2016 Aug 02;4(3). doi: 10.3390/vaccines4030027. PMID: 27490575; PMCID: PMC5041021.
Copy Download .nbib Format: NLM
COVID-19 Infection - the Possibility to Involve Oxygen as Immunogen in the ARDS Determinism (Acute Respiratory Distress Syndrome).

Maedica

Ghimpu M.
PMID: 34925610
Maedica (Bucur). 2021 Sep;16(3):507-515. doi: 10.26574/maedica.2020.16.3.507.

Since its onset, the new coronavirus SARS-CoV-2 has manifested multiple paradoxes related to both complications of the infection and treatment resistance. The experiences in therapy started from the use of neutralizing monoclonal antibodies and anti-cytokine therapy (anti IL-6, anti-TNF-alpha...

Cite
Ghimpu M. COVID-19 Infection - the Possibility to Involve Oxygen as Immunogen in the ARDS Determinism (Acute Respiratory Distress Syndrome). Maedica (Bucur). 2021;16(3):507-515doi: 10.26574/maedica.2020.16.3.507.
Ghimpu, M. (2021). COVID-19 Infection - the Possibility to Involve Oxygen as Immunogen in the ARDS Determinism (Acute Respiratory Distress Syndrome). Maedica, 16(3), 507-515. https://doi.org/10.26574/maedica.2020.16.3.507
Ghimpu, Mihaela. "COVID-19 Infection - the Possibility to Involve Oxygen as Immunogen in the ARDS Determinism (Acute Respiratory Distress Syndrome)." Maedica vol. 16,3 (2021): 507-515. doi: https://doi.org/10.26574/maedica.2020.16.3.507
Ghimpu M. COVID-19 Infection - the Possibility to Involve Oxygen as Immunogen in the ARDS Determinism (Acute Respiratory Distress Syndrome). Maedica (Bucur). 2021 Sep;16(3):507-515. doi: 10.26574/maedica.2020.16.3.507. PMID: 34925610; PMCID: PMC8643563.
Copy Download .nbib Format: NLM
Genetic signatures of Mycobacterium tuberculosis Nonthaburi genotype revealed by whole genome analysis of isolates from tuberculous meningitis patients in Thailand.

PeerJ

Coker OO, Chaiprasert A, Ngamphiw C, Tongsima S, Regmi SM, Clark TG, Ong RT, Teo YY, Prammananan T, Palittapongarnpim P.
PMID: 27114869
PeerJ. 2016 Apr 12;4:e1905. doi: 10.7717/peerj.1905. eCollection 2016.

Genome sequencing plays a key role in understanding the genetic diversity of Mycobacterium tuberculosis (M.tb). The genotype-specific character of M. tb contributes to tuberculosis severity and emergence of drug resistance. Strains of M. tb complex can be classified into...

Cite
Coker OO, Chaiprasert A, Ngamphiw C, et al. Genetic signatures of Mycobacterium tuberculosis Nonthaburi genotype revealed by whole genome analysis of isolates from tuberculous meningitis patients in Thailand. PeerJ. 2016;4:e1905doi: 10.7717/peerj.1905.
Coker, O. O., Chaiprasert, A., Ngamphiw, C., Tongsima, S., Regmi, S. M., Clark, T. G., Ong, R. T., Teo, Y. Y., Prammananan, T., & Palittapongarnpim, P. (2016). Genetic signatures of Mycobacterium tuberculosis Nonthaburi genotype revealed by whole genome analysis of isolates from tuberculous meningitis patients in Thailand. PeerJ, 4e1905. https://doi.org/10.7717/peerj.1905
Coker, Olabisi Oluwabukola, et al. "Genetic signatures of Mycobacterium tuberculosis Nonthaburi genotype revealed by whole genome analysis of isolates from tuberculous meningitis patients in Thailand." PeerJ vol. 4 (2016): e1905. doi: https://doi.org/10.7717/peerj.1905
Coker OO, Chaiprasert A, Ngamphiw C, Tongsima S, Regmi SM, Clark TG, Ong RT, Teo YY, Prammananan T, Palittapongarnpim P. Genetic signatures of Mycobacterium tuberculosis Nonthaburi genotype revealed by whole genome analysis of isolates from tuberculous meningitis patients in Thailand. PeerJ. 2016 Apr 12;4:e1905. doi: 10.7717/peerj.1905. eCollection 2016. PMID: 27114869; PMCID: PMC4841212.
Copy Download .nbib Format: NLM
Cancer immunotherapy: is there real progress at last?.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Kammula US, Marincola FM.
PMID: 18031135
BioDrugs. 1999 Apr;11(4):249-60. doi: 10.2165/00063030-199911040-00004.

This review summarises the evolution of recent major advances in cancer immunotherapy, using metastatic melanoma as a model. The first true clinical progress with immunotherapy developed from the application of recombinant DNA technology for the large scale production of...

Cite
Kammula US, Marincola FM. Cancer immunotherapy: is there real progress at last?. BioDrugs. 1999;11(4):249-60doi: 10.2165/00063030-199911040-00004.
Kammula, U. S., & Marincola, F. M. (1999). Cancer immunotherapy: is there real progress at last?. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 11(4), 249-60. https://doi.org/10.2165/00063030-199911040-00004
Kammula, U S, and Marincola, F M. "Cancer immunotherapy: is there real progress at last?." BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 11,4 (1999): 249-60. doi: https://doi.org/10.2165/00063030-199911040-00004
Kammula US, Marincola FM. Cancer immunotherapy: is there real progress at last?. BioDrugs. 1999 Apr;11(4):249-60. doi: 10.2165/00063030-199911040-00004. PMID: 18031135.
Copy Download .nbib Format: NLM
Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study.

Allergy

Horn MP, Jonsdottir HR, Brigger D, Damonti L, Suter-Riniker F, Endrich O, Froehlich TK, Fiedler M, Largiadèr CR, Marschall J, Weber B, Eggel A, Nagler M.
PMID: 34986501
Allergy. 2022 Jan 05; doi: 10.1111/all.15206. Epub 2022 Jan 05.

BACKGROUND: Serological tests are a powerful tool in the monitoring of infectious diseases and the detection of host immunity. However, manufacturers often provide diagnostic accuracy data generated through biased studies, and the performance in clinical practice is essentially unclear.OBJECTIVES:...

Cite
Horn MP, Jonsdottir HR, Brigger D, et al. Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study. Allergy. 2022;doi: 10.1111/all.15206.
Horn, M. P., Jonsdottir, H. R., Brigger, D., Damonti, L., Suter-Riniker, F., Endrich, O., Froehlich, T. K., Fiedler, M., Largiadèr, C. R., Marschall, J., Weber, B., Eggel, A., & Nagler, M. (2022). Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study. Allergy, . https://doi.org/10.1111/all.15206
Horn, Michael P, et al. "Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study." Allergy vol. (2022). doi: https://doi.org/10.1111/all.15206
Horn MP, Jonsdottir HR, Brigger D, Damonti L, Suter-Riniker F, Endrich O, Froehlich TK, Fiedler M, Largiadèr CR, Marschall J, Weber B, Eggel A, Nagler M. Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study. Allergy. 2022 Jan 05; doi: 10.1111/all.15206. Epub 2022 Jan 05. PMID: 34986501.
Copy Download .nbib Format: NLM
COVID-19 Infection - the Possibility to Involve Oxygen as Immunogen in the ARDS Determinism (Acute Respiratory Distress Syndrome).

Maedica

Ghimpu M.
PMID: 34925610
Maedica (Bucur). 2021 Sep;16(3):507-515. doi: 10.26574/maedica.2020.16.3.507.

Since its onset, the new coronavirus SARS-CoV-2 has manifested multiple paradoxes related to both complications of the infection and treatment resistance. The experiences in therapy started from the use of neutralizing monoclonal antibodies and anti-cytokine therapy (anti IL-6, anti-TNF-alpha...

Cite
Ghimpu M. COVID-19 Infection - the Possibility to Involve Oxygen as Immunogen in the ARDS Determinism (Acute Respiratory Distress Syndrome). Maedica (Bucur). 2021;16(3):507-515doi: 10.26574/maedica.2020.16.3.507.
Ghimpu, M. (2021). COVID-19 Infection - the Possibility to Involve Oxygen as Immunogen in the ARDS Determinism (Acute Respiratory Distress Syndrome). Maedica, 16(3), 507-515. https://doi.org/10.26574/maedica.2020.16.3.507
Ghimpu, Mihaela. "COVID-19 Infection - the Possibility to Involve Oxygen as Immunogen in the ARDS Determinism (Acute Respiratory Distress Syndrome)." Maedica vol. 16,3 (2021): 507-515. doi: https://doi.org/10.26574/maedica.2020.16.3.507
Ghimpu M. COVID-19 Infection - the Possibility to Involve Oxygen as Immunogen in the ARDS Determinism (Acute Respiratory Distress Syndrome). Maedica (Bucur). 2021 Sep;16(3):507-515. doi: 10.26574/maedica.2020.16.3.507. PMID: 34925610; PMCID: PMC8643563.
Copy Download .nbib Format: NLM
Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study.

Allergy

Horn MP, Jonsdottir HR, Brigger D, Damonti L, Suter-Riniker F, Endrich O, Froehlich TK, Fiedler M, Largiadèr CR, Marschall J, Weber B, Eggel A, Nagler M.
PMID: 34986501
Allergy. 2022 Jan 05; doi: 10.1111/all.15206. Epub 2022 Jan 05.

BACKGROUND: Serological tests are a powerful tool in the monitoring of infectious diseases and the detection of host immunity. However, manufacturers often provide diagnostic accuracy data generated through biased studies and the performance in clinical practice is essentially unclear.OBJECTIVES:...

Cite
Horn MP, Jonsdottir HR, Brigger D, et al. Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study. Allergy. 2022;doi: 10.1111/all.15206.
Horn, M. P., Jonsdottir, H. R., Brigger, D., Damonti, L., Suter-Riniker, F., Endrich, O., Froehlich, T. K., Fiedler, M., Largiadèr, C. R., Marschall, J., Weber, B., Eggel, A., & Nagler, M. (2022). Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study. Allergy, . https://doi.org/10.1111/all.15206
Horn, Michael P, et al. "Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study." Allergy vol. (2022). doi: https://doi.org/10.1111/all.15206
Horn MP, Jonsdottir HR, Brigger D, Damonti L, Suter-Riniker F, Endrich O, Froehlich TK, Fiedler M, Largiadèr CR, Marschall J, Weber B, Eggel A, Nagler M. Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study. Allergy. 2022 Jan 05; doi: 10.1111/all.15206. Epub 2022 Jan 05. PMID: 34986501.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 3774 entries